All lobbying filings

FOLEY HOAG LLP

FOLEY HOAG LLP filed a Q4 report for TONIX PHARMACEUTICALS on January 19, 2026, reporting $20,000 in lobbying income.

Lobbying for TONIX PHARMACEUTICALS · Manufacturer of pharmaceutical products.

All filings by FOLEY HOAG LLP · Everything TONIX PHARMACEUTICALS has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues pertaining to access to non-opioid alternatives

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.